This company listing is no longer active

This company may still be operating, however this listing is no longer active. Find out why through their latest events.

Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!

Jayex Technology Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Jayex Technology's earnings have been declining at an average annual rate of -38.9%, while the Healthcare Services industry saw earnings growing at 13.5% annually. Revenues have been declining at an average rate of 13.5% per year.

Anahtar bilgiler

-38.9%

Kazanç büyüme oranı

-30.1%

EPS büyüme oranı

Healthcare Services Sektör Büyümesi	42.6%
Gelir büyüme oranı	-13.5%
Özkaynak getirisi	n/a
Net Marj	-103.1%
Son Kazanç Güncellemesi	31 Dec 2023

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Jayex Technology nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

CHIA:JTL Gelir, gider ve kazançlar (AUD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
31 Dec 23	4	-4	2
30 Sep 23	4	-5	2
30 Jun 23	4	-6	2
31 Mar 23	4	-6	2
31 Dec 22	5	-6	2
30 Sep 22	5	-5	2
30 Jun 22	5	-3	2
31 Mar 22	5	-4	2
31 Dec 21	5	-4	2
30 Sep 21	4	-3	2
30 Jun 21	4	-3	1
31 Mar 21	5	-2	2
31 Dec 20	6	-1	2
30 Sep 20	6	-1	1
30 Jun 20	7	0	1
31 Mar 20	7	-1	1
31 Dec 19	7	-1	1
30 Sep 19	7	-1	1
30 Jun 19	7	-1	2
31 Mar 19	7	-1	2
31 Dec 18	7	-1	2
30 Sep 18	7	-1	2
30 Jun 18	7	-1	2
31 Mar 18	7	-2	2
31 Dec 17	8	-2	2
30 Sep 17	7	-4	2
30 Jun 17	7	-5	2
31 Mar 17	8	-5	2
31 Dec 16	9	-5	2
30 Jun 16	7	-4	2
31 Mar 16	4	-4	1
31 Dec 15	2	-3	1
30 Jun 15	1	-1	1
30 Jun 14	0	0	0

Kaliteli Kazançlar: JTL is currently unprofitable.

Büyüyen Kar Marjı: JTL is currently unprofitable.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: JTL kârlı değil ve zararlar son 5 yılda yılda 38.9% oranında arttı.

Büyüme Hızlandırma: Unable to compare JTL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Kazançlar vs. Sektör: JTL is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare Services industry (7.1%).

Özkaynak Getirisi

Yüksek ROE: JTL's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.

This company listing is no longer active

Jayex Technology Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

First half 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2022)

Full year 2022 earnings released: AU$0.024 loss per share (vs AU$0.019 loss in FY 2021)

First half 2022 earnings released: AU$0.004 loss per share (vs AU$0.008 loss in 1H 2021)

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Recent updates

High number of new directors

Jayex Technology Limited Announces Board Changes

Jayex Technology Limited, Annual General Meeting, Jul 04, 2024

Less than half of directors are independent

Jayex Technology Limited Announces Directorate Changes

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

First half 2023 earnings released: AU$0.003 loss per share (vs AU$0.004 loss in 1H 2022)

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Less than half of directors are independent

Full year 2022 earnings released: AU$0.024 loss per share (vs AU$0.019 loss in FY 2021)

Jayex Technology Limited Announces Resignation of Nathan Woodard as Chief Financial Officer, Effective January 31, 2023

No independent directors

No independent directors

Jayex Technology Limited Announces Resignation of Michael Chan as Non-Executive Director

No independent directors

No independent directors

Jayex Technology Limited Appoints Robert Hadle as Chief Executive Officer, Effective 3 October 2022

First half 2022 earnings released: AU$0.004 loss per share (vs AU$0.008 loss in 1H 2021)

No independent directors

No independent directors

No independent directors

Jayex Technology Limited, Annual General Meeting, May 26, 2022

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

No independent directors

Jayex Technology Limited has completed a Follow-on Equity Offering in the amount of AUD 0.572723 million.

Jayex Healthcare Limited announced that it expects to receive AUD 0.572723 million in funding

Vitalhub Corp. (TSXV:VHI) completed the acquisition of Assets of On-premises Acute (hospital) queue management business of Jayex Healthcare Limited (ASX:JHL).

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

Jayex Healthcare Limited, Annual General Meeting, May 27, 2021

Full year 2020 earnings released: AU$0.004 loss per share (vs AU$0.006 loss in FY 2019)

MyFiziq Limited Signs Binding Term Sheet with Jayex Healthcare Limited

Jayex Healthcare Limited announced that it expects to receive AUD 0.7 million in funding

First half earnings released

Jayex Healthcare Limited Announces Resignation of Nick Fernando as Group Chief Executive Officer Effective 25 July 2020

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin